Table 1.
Open in new tab

Age and Time Since The First Dose in Participants Stratified by Dosing Schedulea

0–2 y Since 1st Dose (n = 145)2–3 y Since 1st Dose (n = 118)3–4 y Since 1st Dose (n = 106)4–4½ y Since 1st Dose (n = 97)
3 Doses (n = 89)2 Doses (n = 56)P Value3 Doses (n = 81)2 Doses (n = 37)P Value3 Doses (n = 73)2 Doses (n = 33)P Value3 Doses (n = 74)2 Doses (n = 23)P Value
Age, median (range), y14 (13–15)14 (13–15).7315 (14–16)15 (14–16).1016 (15–17)16 (15–17).7517 (16–17)17 (16–17).83
Duration since 1st dose, median (range), d562 (525–728)549.5 (337–728).02924 (895–940)915 (742–1092).101290 (1237–1449)1265 (1120–1456).031625.5 (1568–1647)1624 (1478–1644).18
0–2 y Since 1st Dose (n = 145)2–3 y Since 1st Dose (n = 118)3–4 y Since 1st Dose (n = 106)4–4½ y Since 1st Dose (n = 97)
3 Doses (n = 89)2 Doses (n = 56)P Value3 Doses (n = 81)2 Doses (n = 37)P Value3 Doses (n = 73)2 Doses (n = 33)P Value3 Doses (n = 74)2 Doses (n = 23)P Value
Age, median (range), y14 (13–15)14 (13–15).7315 (14–16)15 (14–16).1016 (15–17)16 (15–17).7517 (16–17)17 (16–17).83
Duration since 1st dose, median (range), d562 (525–728)549.5 (337–728).02924 (895–940)915 (742–1092).101290 (1237–1449)1265 (1120–1456).031625.5 (1568–1647)1624 (1478–1644).18

aData in Table 1 represent all participants.

Table 1.
Open in new tab

Age and Time Since The First Dose in Participants Stratified by Dosing Schedulea

0–2 y Since 1st Dose (n = 145)2–3 y Since 1st Dose (n = 118)3–4 y Since 1st Dose (n = 106)4–4½ y Since 1st Dose (n = 97)
3 Doses (n = 89)2 Doses (n = 56)P Value3 Doses (n = 81)2 Doses (n = 37)P Value3 Doses (n = 73)2 Doses (n = 33)P Value3 Doses (n = 74)2 Doses (n = 23)P Value
Age, median (range), y14 (13–15)14 (13–15).7315 (14–16)15 (14–16).1016 (15–17)16 (15–17).7517 (16–17)17 (16–17).83
Duration since 1st dose, median (range), d562 (525–728)549.5 (337–728).02924 (895–940)915 (742–1092).101290 (1237–1449)1265 (1120–1456).031625.5 (1568–1647)1624 (1478–1644).18
0–2 y Since 1st Dose (n = 145)2–3 y Since 1st Dose (n = 118)3–4 y Since 1st Dose (n = 106)4–4½ y Since 1st Dose (n = 97)
3 Doses (n = 89)2 Doses (n = 56)P Value3 Doses (n = 81)2 Doses (n = 37)P Value3 Doses (n = 73)2 Doses (n = 33)P Value3 Doses (n = 74)2 Doses (n = 23)P Value
Age, median (range), y14 (13–15)14 (13–15).7315 (14–16)15 (14–16).1016 (15–17)16 (15–17).7517 (16–17)17 (16–17).83
Duration since 1st dose, median (range), d562 (525–728)549.5 (337–728).02924 (895–940)915 (742–1092).101290 (1237–1449)1265 (1120–1456).031625.5 (1568–1647)1624 (1478–1644).18

aData in Table 1 represent all participants.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close